Pesancort Medipharco skin cream for psoriasis, keloid scars, lupus discs (5g)

Dosage form Tube
Specifications Fusidic acid, betamethasone valeate

Ingredient

Thành phần cho 5g

Composition information	Content
Fusidic Acid	2%
Betamethason Valeration	0.1%

Uses

Indications

Pesancort® 5 G is indicated in the following cases:

Treatment of localized, hyperplasia lesions of flat liken, psoriasis, keloid scars, lupus discs, lupus erythematosus diverse, peeling dermatitis, contact dermatitis , atopic dermatitis and insect burner. Steroid structure, belonging to fusidanin group, has bactericidal and bactericidal effects, mainly acting on gram -positive bacteria.

Fusidic acid inhibits protein bacteria through inhibiting a essential factor for the transfer of peptid supplementary units and extending the peptide chain.

Although fusidic acid has the ability to inhibit protein synthesis in mammal cells, but due to the ability to penetrate very poorly into the host cell, the drug has a selective effect against sensitive bacteria.

Fusidic acid is very effective to fight staphylococcus strains, especially S.Aureus and S.Pidermis, Nocardia Osteroides and many Clostridioides strains are also very sensitive to the drug. Streptococcus and Enterococcus strains are less sensitive.

betamethasone valeate is a synthetic corticoid, anti -inflammatory and anti -allergy effect, used to treat skin diseases that respond to corticosteroids.

Dynamic pharmacokinetics

Fusidic acid absorb well through the skin and see in all skin and subcutaneous structures.

Betamethasone valeate is easily absorbed when used on the spot. When applied, especially if the skin is closed or when the skin is torn, there may be a betamethasone .

betamethason quickly distributed into all tissues in the body. The drug through the placenta and can be exported to breast milk in small amounts. Betamethasone Valerate metabolizes mainly in the liver, kidneys and exit into the urine.

Before taking Pesancort Medipharco skin cream for psoriasis, keloid scars, lupus discs (5g)

How to use

Pesancort® 5 G topical.

Dosage

Apply a thin layer of drug 1-2 times daily to the infected skin after washing. Avoid applying the drug into thick layer. Avoid long -term continuous treatment, especially with the face.

Limit treatment in 1 week.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using pesancort® 5 g , you may experience unwanted effects (ADR).

Very rarely have hypersensitivity reactions when used on topical skin, there are some unwanted effects such as atopic dermatitis, urticaria , vasodilic edema.

Prolonged and high doses of skin, skin pattern, shallow blood vessels, especially when covered or applied to the skin with many folds.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Pesancort® 5 G control in the following cases:

Hypersensitivity to the ingredients of the drug.

Infections, viral infections, systemic fungal infections.

Pregnant women.

Patients with liver failure.

Caution when using

only used on the skin, not applied to the eyes.

Treatment time should be limited within 7 days, except for acne treatment, to avoid selecting sensitive bacteria.

Located use, the drug can be absorbed in the whole body in the case of wide skin damage or leg ulcers.

Do not take the drug continuously for a long time, especially on the face, folds, intimidation areas, children with children and older children. Do not use much in pregnant and lactating women.

If there is irritation or sensitivity, stop treatment and replace it with other drugs.

The ability to drive and operate machinery

The drug does not affect the ability to drive and operate machinery.

Pregnancy

should not be used for pregnant women.

Breastfeeding period

Export medicine in breast milk and may be harmful to children. Benefits for mothers must be considered with the ability to harm children.

Drug interaction

Fusidic acid has an antagonistic effect with ciprofloxacin and complex interaction with penicillin.

There may be mutual metabolic inhibits between antiviral drugs inhibiting protease and fusidic acid, causing these concentrations to increase in plasma, which can cause poisoning. Therefore, avoid using these drugs.

paracetamol high doses or acting fields: Increased risk of liver toxicity.

Oral or insulin anti -diabetic drugs: can increase blood glucose levels.

glycoside digitalis: may increase the possibility of arrhythmia or toxicity of digitalis and hypotension.

Phenobarbital, phenytoin , rifampicin or ephedrine: can increase metabolism and reduce the treatment effect of betamethasone.

Coumarin anticoagulant drugs: can increase or decrease anticoagulant effects.

Storage

In a dry place, temperatures below 30ºC, avoiding light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.